Comparative Safety Analysis of Serious Adverse Drug Events in North America: A 19-Year Study of FDA and Canadian Vigilance Databases

被引:0
|
作者
Chalabianloo, Niaz [1 ,2 ,3 ]
Sedig, Kamran [3 ]
Muanda, Flory Tsobo [1 ,2 ,4 ,5 ]
机构
[1] Western Univ, Dept Physiol & Pharmacol, London, ON, Canada
[2] ICES Western, London, ON, Canada
[3] Western Univ, Dept Comp Sci, London, ON, Canada
[4] Lawson Hlth Res Inst, London, ON, Canada
[5] Western Univ, Dept Epidemiol Biostat, London, ON, Canada
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
134
引用
收藏
页码:1376 / 1377
页数:2
相关论文
共 37 条
  • [11] Adverse drug events in the prevention and treatment of COVID-19: A data mining study on the FDA adverse event reporting system
    Guo, Qiang
    Duan, Shaojun
    Liu, Yaxi
    Yuan, Yinxia
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [12] Clinical adverse events to letairis: a real-world drug safety study based on FDA Adverse Event Reporting System (FAERS)
    Bi, Yu-Ting
    Dong, Bo
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [13] A comparative safety study of reported neurological adverse events with three COVID-19 vaccines
    Sodhi, Mohit
    Samii, Ali
    Etminan, Mahyar
    JOURNAL OF NEUROLOGY, 2022, 269 (05) : 2301 - 2303
  • [14] A comparative safety study of reported neurological adverse events with three COVID-19 vaccines
    Mohit Sodhi
    Ali Samii
    Mahyar Etminan
    Journal of Neurology, 2022, 269 : 2301 - 2303
  • [15] Adverse events of nusinersen: a real-world drug safety surveillance study based on the FDA adverse event reporting system (FAERS) database
    Zhang, Xiaofang
    Gui, Jianxiong
    Wang, Lingman
    Jiang, Chunxue
    Ding, Ran
    Meng, Linxue
    Hong, Siqi
    Jiang, Li
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [16] Adverse events of epidiolex: A real-world drug safety surveillance study based on the FDA adverse event reporting system (FAERS) database
    Zhou, Qin
    Du, Zhiqiang
    Qu, Kankan
    Shen, Yuan
    Jiang, Ying
    Zhu, Haohao
    Zhang, Xiuhong
    ASIAN JOURNAL OF PSYCHIATRY, 2023, 90
  • [17] Adverse events of Capmatinib: A real-world drug safety surveillance study based on the FDA adverse event reporting system (FAERS) database
    Zhang, Hao
    Zhao, Panli
    Huang, Hua
    MEDICINE, 2025, 104 (05)
  • [18] Enhancing antidepressant safety surveillance: comparative analysis of adverse drug reaction signals in spontaneous reporting and healthcare claims databases
    Kim, Taehyung
    Jiang, Xinying
    Noh, Youran
    Kim, Maryanne
    Hong, Song Hee
    FRONTIERS IN PHARMACOLOGY, 2024, 14
  • [19] Serious Cardiovascular Adverse Events Associated with Hydroxychloroquine/Chloroquine Alone or with Azithromycin in Patients with COVID-19: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS)
    Zhao, Ying
    Zhang, Jingru
    Zheng, Kai
    Thai, Sydney
    Simpson, Ross J., Jr.
    Kinlaw, Alan C.
    Xu, Yang
    Wei, Jingkai
    Cui, Xiangli
    Buse, John B.
    Sturmer, Til
    Wang, Tiansheng
    DRUGS-REAL WORLD OUTCOMES, 2022, 9 (02) : 231 - 241
  • [20] Serious Cardiovascular Adverse Events Associated with Hydroxychloroquine/Chloroquine Alone or with Azithromycin in Patients with COVID-19: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS)
    Ying Zhao
    Jingru Zhang
    Kai Zheng
    Sydney Thai
    Ross J. Simpson
    Alan C. Kinlaw
    Yang Xu
    Jingkai Wei
    Xiangli Cui
    John B Buse
    Til Stürmer
    Tiansheng Wang
    Drugs - Real World Outcomes, 2022, 9 : 231 - 241